 | Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight... 90 KB (9,943 words) - 19:53, 12 May 2024 |
for its potential to treat various forms of cancer. Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes... 56 KB (5,783 words) - 08:27, 10 May 2024 |
 | 2016, the Parker Institute for Cancer Immunotherapy scientists funded a clinical trial to test the next wave of cancer-fighting T-cells engineered using... 68 KB (5,653 words) - 17:46, 6 May 2024 |
 | development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance... 33 KB (3,766 words) - 02:41, 25 April 2024 |
 | PD-1 and PD-L1 inhibitors (category Cancer immunotherapy) non-small cell lung cancer, renal cell carcinoma, bladder cancer and Hodgkin lymphoma, amongst other cancer types. Immunotherapy with these immune checkpoint... 31 KB (3,266 words) - 05:22, 6 May 2024 |
 | (FDA). In the European Union, atezolizumab is the first PD-(L)1 cancer immunotherapy for subcutaneous injection. In the European Union, atezolizumab is... 43 KB (4,160 words) - 04:59, 13 April 2024 |
 | Interferon gamma (section Cancer immunotherapy) chromosomal locus. Type II IFN has played a role in the development of cancer immunotherapy treatments due to its ability to prevent tumor growth. IFNG, or type... 56 KB (6,477 words) - 20:41, 8 April 2024 |
 | James P. Allison (category University of Texas MD Anderson Cancer Center faculty) executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas. His discoveries have led to new cancer treatments for... 25 KB (2,156 words) - 09:09, 26 March 2024 |
S2CIDÂ 26656379. Cancer Immunotherapy Consortium (coordinated early-phase clinical trials of therapeutic cancer vaccines) Society for Immunotherapy of Cancer Association... 27 KB (3,133 words) - 15:22, 26 April 2024 |
 | BioNTech (section Cancer immunotherapy) on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement... 40 KB (3,633 words) - 02:16, 24 March 2024 |
 | William Coley (category American cancer researchers) an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection... 17 KB (1,937 words) - 19:26, 7 April 2024 |
clinical cancer research shifted towards therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy. Cancer research... 46 KB (6,559 words) - 17:10, 10 May 2024 |
 | First Immunotherapy Treatment for Lung Cancer - NCI". www.cancer.gov. 24 March 2015. Retrieved 22 September 2023. "Approvals Increase Lung Cancer Treatment... 50 KB (5,301 words) - 01:05, 9 May 2024 |
Individualized cancer immunotherapy, also referred to as individualized immuno-oncology, is a novel concept for therapeutic cancer vaccines that are truly... 25 KB (2,535 words) - 09:22, 8 April 2023 |
 | response. Blockade of A2AR has been attempted to various ends, namely cancer immunotherapy. While several A2A receptor antagonists have progressed to clinical... 46 KB (5,102 words) - 01:13, 8 March 2024 |
 | therapy, and targeted therapy. For certain subtypes of gastric cancer, cancer immunotherapy is an option as well. If treated late, palliative care may be... 79 KB (8,142 words) - 17:15, 6 May 2024 |
 | Other therapies include hyperthermia, immunotherapy, photodynamic therapy, and stem-cell therapy. Most commonly cancer treatment involves a series of separate... 70 KB (8,493 words) - 11:19, 26 February 2024 |
Cancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation... 2 KB (169 words) - 14:31, 29 April 2023 |
 | Pembrolizumab (category Cancer immunotherapy) antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain... 72 KB (6,842 words) - 05:58, 10 April 2024 |
T cell response. DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of cancer patients. Non-activated (immature)... 14 KB (1,616 words) - 21:16, 29 August 2023 |
Sipuleucel-T (category Wikipedia articles incorporating text from the National Cancer Institute Dictionary of Cancer Terms) Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy. Sipuleucel-T is indicated for... 16 KB (1,405 words) - 17:07, 25 November 2023 |
 | Advanced Bladder Cancer". National Cancer Institute. 9 August 2019. Konala VM, Adapa S, Aronow WS (February 2019). "Immunotherapy in Bladder Cancer". American... 137 KB (13,535 words) - 17:38, 29 April 2024 |
 | blockbuster drugs or products each with 2020 revenues including cancer immunotherapy, anti-diabetic medication and vaccines against HPV and chickenpox... 95 KB (9,333 words) - 08:57, 9 May 2024 |
Checkpoint inhibitor (category Cancer immunotherapy) Checkpoint inhibitor therapy is a form of cancer immunotherapy. The therapy targets immune checkpoints, key regulators of the immune system that when stimulated... 21 KB (2,093 words) - 18:53, 25 January 2024 |
RNA therapeutics (section Cancer immunotherapy) mRNA encoding cancer antigens by BioNTech has started with patients with melanoma (NCT01684241). Recently, the new cancer immunotherapy, the combining... 76 KB (8,848 words) - 17:12, 2 May 2024 |
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional... 11 KB (1,064 words) - 15:31, 15 April 2024 |
solid cancer immunotherapy. TRM cells infiltrated in tumors have protective role and are associated with good clinical results in various cancer types... 25 KB (3,011 words) - 01:42, 11 November 2023 |
Neoepitope (category Cancer vaccines) selection for mutanome-directed individualized cancer immunotherapy. Individualized cancer immunotherapy leverages the adaptive immune system by targeting... 13 KB (1,146 words) - 19:53, 6 February 2024 |
The Breakthrough: Immunotherapy and the Race to Cure Cancer is a non-fiction book written by American journalist and author Charles Graeber. The book... 6 KB (606 words) - 05:26, 22 March 2023 |
Oncolytic virus (redirect from Oncolytic immunotherapy) is now marketed under the brand name Oncorine. With advances in cancer immunotherapy such as immune checkpoint inhibitors, increased attention has been... 71 KB (8,503 words) - 16:40, 29 April 2024 |